Frontotemporal Dementia

Plasma NfL as a biomarker for frontotemporal dementia

Diagnostic tools for neurodegenerative disease

Dipeptide repeat proteins and the NLRP3 inflammasome in FTD

Next steps for research into the NLRP3 inflammasome in dementia

Understanding tau proteostasis using iPSC

The role of phosphorylated tau in clinical trials

Using phosphorylated tau as a diagnostic tool for Alzheimer’s disease

Understanding the relationship between MAPT mutations and disease pathology

MAPT mutations in frontotemporal dementia and Alzheimer’s

Exploring new topic areas with the Drug Discovery Institute

An introduction to familial frontotemporal dementia

The role of inflammation in FTD

Matching mechanisms and therapeutics: new avenues to explore

Traumatic brain injuries and the development of dementia

The neuropathology and genetics of ALS and FTD

ALS and frontotemporal dementia: on a continuum or part of a spectrum of disorders?